11/7 Live streamed Harvard event: “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South”

Live streamed Harvard event on adolescent mental health beyond the clinic.  The Child Mental Health Forum talks run through May. 10 AM- 11:15 a.m.  at the Judge Baker Children’s Center 53 Parker Hill Avenue, Boston, Limited free parking available November 7th, 2018 “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South” Vikram Patel, … Continue reading 11/7 Live streamed Harvard event: “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South”

Advertisements

STAT: :Neuroinflammation is where we’re going to find [Alzheimer’s] drugs.”

That's what Rudolph Tanzi, a prominent Alzheimer's researcher at MGH says about the work of Robert Moir, a member of his team.  A story in STAT last week -- which ran in today's Globe - chronicles Moir's struggle to get funding for a theory that Alzheimer’s disease is a triggered by microbes in the brain. "If true, the … Continue reading STAT: :Neuroinflammation is where we’re going to find [Alzheimer’s] drugs.”

KHN: Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus

defaultEmmarie Huetteman and Sydney Lupkin, Kaiser Health News Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress. Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two of those — Reps. … Continue reading KHN: Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus

Is the US setting the bar too low for new CF drug? Canada says it’s not worth it

From The Globe and Mail: Canadian governments should not pay for a $250,000-a-year cystic fibrosis medication because it is not clear the drug actually improves patients’ health, according to a fresh review that has devastated some with the potentially fatal lung disease.... In a report released on Thursday, the CADTH’s expert panel said its review … Continue reading Is the US setting the bar too low for new CF drug? Canada says it’s not worth it

Harvard study find that #immigrants’ #health #premiums exceed cost of care; Kaiser Health News explains

Carmen Heredia Rodriguez, Kaiser Health News President Donald Trump has repeatedly condemned U.S. immigration policy, arguing that many immigrants pose a threat to the nation and drain U.S. resources. But a study released Monday about health insurance challenges the president’s portrayal. The study in the journal Health Affairs found that immigrants covered by private health … Continue reading Harvard study find that #immigrants’ #health #premiums exceed cost of care; Kaiser Health News explains

Wednesday offers a burst of health #events in #Boston covering outbreaks, drug costs, AI and more

Wednesday 9/26 seems to be an extraordinary day for health and medicine events. Thanks to the calendar listing on   "Selected Lectures on Science and Engineering in the Boston Area" 10-1p.  "Media in the Age of Contagions."   A symposium.   HLS:  Wasserstein Hall, Milstein West (2019), 1585 Massachusetts Ave.   Details, Abstract, Registration. Noon.  "U.S. Drug Prices: Why Are … Continue reading Wednesday offers a burst of health #events in #Boston covering outbreaks, drug costs, AI and more

From MIT’s Undark: More and More, New Drugs Clear the FDA With ‘Accelerated Approval’

Increasing reliance on this and other means of moving drugs quickly to market have many critics worried, given that drugmakers benefit most. September 10, 2018 by Abigail Fagan & Mark Kaufman On June 28, 2011, ten police cars descended upon the headquarters of the Food and Drug Administration. Scores of protesters carrying loudspeakers and donning … Continue reading From MIT’s Undark: More and More, New Drugs Clear the FDA With ‘Accelerated Approval’